KRT16 and ovarian cancer: Only KTR14, KRT16, CXCL9, and CFD in BRCA1 Ovarian Cancer and TSPAN7 and CDKN2C in BRCA2 ovarian cancers were highly upregulated, and KANK4, MFGE8, LINC00346, and SA100A1 in BRCA1 mutated breast cancer, and MAGEA4 in BRCA2 breast cancers.